ArticleGastroenterology & hepatology2021
IMMUTACE: A Phase 2 Single-Arm, Open-Label Study of Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate-Stage Hepatocellular Carcinoma.
No numbers read from the abstract.
11 papers cite it
this papercites it